Seattle Genetics Presents Data from Phase 2 Study Evaluating ADCETRIS® (Brentuximab Vedotin) in Frontline Diffuse Large B-cell Lymphoma at ASH Annual Meeting
Seattle Genetics Presents Phase 1b Data from Vadastuximab Talirine (SGN-CD33A; 33A) in Combination with Standard of Care in Frontline Acute Myeloid Leukemia at ASH Annual Meeting
City of Hope physicians present new research at 2016 American Society of Hematology meeting
UPDATE: Dow slips after 4 record closing highs in a row
World's First Reported Transcatheter Tricuspid Repair Procedure in Patient with Cardiac Implantable Device Lead Performed Using Trialign™ System
Rekenthaler drop-kicks PBS' documentary.
Tuttle Tactical Management, LLC is an investment adviser registered with the U.S. Securities and Exchange Commission. You should not assume that any discussion or information contained in this letter serves as the receipt of, or as a substitute for, personalized investment advice from Tuttle ...
Amid soaring prices, financial planners need a role in solving what ails U.S. universities.
Prudent Investor Advisors' Scott Simon offers thoughts on the recent PBS' Frontline broadcast.